Prognostic factors in prostate cancer

A Buhmeida, S Pyrhönen, M Laato, Y Collan - Diagnostic pathology, 2006 - Springer
Prognostic factors in organ confined prostate cancer will reflect survival after surgical radical
prostatectomy. Gleason score, tumour volume, surgical margins and Ki-67 index have the …

TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?

L Zhang, GJ Barritt - Endocrine-related cancer, 2006 - erc.bioscientifica.com
During the past 5 years it has emerged that the transient receptor potential (TRP) family of
Ca 2+-and Na+-permeable channels plays a diverse and important role in cell biology and …

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis

M Selman, A Pardo, L Barrera, A Estrada… - American journal of …, 2006 - atsjournals.org
Rationale: Many of the interstitial lung diseases represent a diagnostic and therapeutic
challenge because their clinical and even histologic features are often nonspecific …

Evolution of the androgen receptor pathway during progression of prostate cancer

PJM Hendriksen, NFJ Dits, K Kokame, A Veldhoven… - Cancer research, 2006 - AACR
The present work focused on the potential involvement of selective adaptations of the
androgen receptor pathway in the initiation and progression of prostate cancer. We defined …

Quantitative multi‐gene expression profiling of primary prostate cancer

U Schmidt, S Fuessel, R Koch, GB Baretton… - The …, 2006 - Wiley Online Library
BACKGROUND This study describes the evaluation of the expression patterns of prostate‐
related transcripts in 106 matched prostate tissues from prostatectomies as predictors for …

A distinct molecular profile associated with mucinous epithelial ovarian cancer

VA Heinzelmann-Schwarz, M Gardiner-Garden… - British journal of …, 2006 - nature.com
Mucinous epithelial ovarian cancers (MOC) are clinically and morphologically distinct from
the other histological subtypes of ovarian cancer. To determine the genetic basis of MOC …

Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial

S Fuessel, A Meye, M Schmitz, S Zastrow… - The …, 2006 - Wiley Online Library
Background Immunotherapies might represent promising alternatives for the treatment of
patients with hormone‐refractory prostate cancer (HRPC). In a Phase I clinical trial, we …

Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy

SM Henshall, LG Horvath, DI Quinn… - Journal of the …, 2006 - academic.oup.com
The risk of metastatic progression for prostate cancer patients who undergo radical
prostatectomy is best estimated presently based on prostate-specific antigen (PSA) doubling …

[图书][B] Cancer diagnostics with DNA microarrays

S Knudsen - 2006 - books.google.com
Authored by an international authority in the field, Cancer Diagnostics with DNA Microarrays
is a complete reference work on the rapidly growing use of DNA microarray data in the …

Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with …

L Hammock, C Cohen, G Carlson… - Journal of cutaneous …, 2006 - Wiley Online Library
Objective: To determine whether loss of melastatin (MLSN) is a universal phenomenon in
American Joint Committee on Cancer (AJCC) stage I and II melanoma patients who …